Literature DB >> 21296819

Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort.

James M Stringham1, Paul V Garcia, Peter A Smith, Leon N McLin, Brian K Foutch.   

Abstract

PURPOSE: One theory of macular pigment's (MP) presence in the fovea is to improve visual performance in glare. This study sought to determine the effect of MP level on three aspects of visual performance in glare: photostress recovery, disability glare, and visual discomfort.
METHODS: Twenty-six subjects participated in the study. Spatial profiles of MP optical density were assessed with heterochromatic flicker photometry. Glare was delivered via high-bright-white LEDs. For the disability glare and photostress recovery portions of the experiment, the visual task consisted of correct identification of a 1° Gabor patch's orientation. Visual discomfort during the glare presentation was assessed with a visual discomfort rating scale. Pupil diameter was monitored with an infrared (IR) camera.
RESULTS: MP level correlated significantly with all the outcome measures. Higher MP optical densities (MPODs) resulted in faster photostress recovery times (average P < 0.003), lower disability glare contrast thresholds (average P < 0.004), and lower visual discomfort (P = 0.002). Smaller pupil diameter during glare presentation significantly correlated with higher visual discomfort ratings (P = 0.037).
CONCLUSIONS: MP correlates with three aspects of visual performance in glare. Unlike previous studies of MP and glare, the present study used free-viewing conditions, in which effects of iris pigmentation and pupil size could be accounted for. The effects described, therefore, can be extended more confidently to real-world, practical visual performance benefits. Greater iris constriction resulted (paradoxically) in greater visual discomfort. This finding may be attributable to the neurobiologic mechanism that mediates the pain elicited by light.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296819     DOI: 10.1167/iovs.10-6699

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  30 in total

Review 1.  Lutein and Zeaxanthin Isomers in Eye Health and Disease.

Authors:  Julie Mares
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

2.  Macular pigment spatial distribution effects on glare disability.

Authors:  Christopher M Putnam; Carl J Bassi
Journal:  J Optom       Date:  2015-02-16

3.  Fruit and vegetable consumption and its relation to risk of asthenopia among Chinese college students.

Authors:  Fang Guo; Qiang Zhang; Meng-Nan Fan; Le Ma; Chu Chen; Xiao-Hong Liu; Hong Jiang; Yan Liu
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

4.  Two-wavelength fundus autofluorescence and macular pigment optical density imaging in diabetic macular oedema.

Authors:  S M Waldstein; D Hickey; I Mahmud; C A Kiire; P Charbel Issa; N V Chong
Journal:  Eye (Lond)       Date:  2012-06-15       Impact factor: 3.775

Review 5.  What is meso-zeaxanthin, and where does it come from?

Authors:  J M Nolan; K Meagher; S Kashani; S Beatty
Journal:  Eye (Lond)       Date:  2013-05-24       Impact factor: 3.775

6.  Reflection-based imaging of macular pigment distributions in infants and children.

Authors:  Mohsen Sharifzadeh; Paul S Bernstein; Werner Gellermann
Journal:  J Biomed Opt       Date:  2013-11       Impact factor: 3.170

7.  Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study.

Authors:  Kristin J Meyers; Elizabeth J Johnson; Paul S Bernstein; Sudha K Iyengar; Corinne D Engelman; Chitra K Karki; Zhe Liu; Robert P Igo; Barbara Truitt; Michael L Klein; D Max Snodderly; Barbara A Blodi; Karen M Gehrs; Gloria E Sarto; Robert B Wallace; Jennifer Robinson; Erin S LeBlanc; Gregory Hageman; Lesley Tinker; Julie A Mares
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

Review 8.  Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.

Authors:  Paul S Bernstein; Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Rajalekshmy Shyam; Bradley S Henriksen; John M Nolan
Journal:  Prog Retin Eye Res       Date:  2015-11-02       Impact factor: 21.198

9.  Supplementation with macular carotenoids improves visual performance of transgenic mice.

Authors:  Binxing Li; Gregory T Rognon; Ty Mattinson; Preejith P Vachali; Aruna Gorusupudi; Fu-Yen Chang; Arunkumar Ranganathan; Kelly Nelson; Evan W George; Jeanne M Frederick; Paul S Bernstein
Journal:  Arch Biochem Biophys       Date:  2018-05-06       Impact factor: 4.013

10.  The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.

Authors:  Christopher J Hammond; S H Melissa Liew; Frederik J Van Kuijk; Stephen Beatty; John M Nolan; Tim D Spector; Clare E Gilbert
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-26       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.